Inflammation-associated cell cycle-independent block of apoptosis by survivin in terminally differentiated neutrophils

Journal of Experimental Medicine

Volumn 199, Issue 10, 2004, Pages 1343-1354

  Altznauer, Frank ^a   Martinelli, Sibylla ^a   Yousefi, Shida ^a   Thürig, Christine ^a   Schmid, Inès ^a   Conway, Edward M ^b   Schöni, Martin H ^a   Vogt, Peter ^c   Mueller, Christoph ^a   Fey, Martin F ^a   Zangemeister Wittke, Uwe ^c   Simon, Hans Uwe ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Antisense; Cancer; Cytokines; Differentiation; Infection

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; SURVIVIN;

APOPTOSIS; ARTICLE; CANCER THERAPY; CELL CYCLE; CELL CYCLE G2 PHASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INFLAMMATION; LIFESPAN; NEUTROPHIL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; APOPTOSIS; BONE MARROW CELLS; CELL CYCLE; CELL DIFFERENTIATION; CELLS, CULTURED; GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT; GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTORS, RECOMBINANT; HUMANS; INFLAMMATION; MICE; MICE, KNOCKOUT; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; NEOPLASM STAGING; NEOPLASMS; NEUTROPHILS;

EID: 2542466891     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20032033     Document Type: Article

References (46)

1. Salvesen, G.S., and C.S. Duckett. 2002. IAP proteins: blocking the road to death's door. Nat. Rev. 3:401-410.
2. Tamm, I., Y. Wang, E. Sausville, D.A. Scudiero, N. Vigna, T. Oltersdorf, and J.C. Reed. 1998. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res. 58:5315-5320.
3. Reed, J.-C., and R.I. Reed. 1999. Survivin' cell-separation anxiety. Nat. Cell Biol. 1:E199-E200.
4. Reed, J.-C., and J.R. Bischoff. 2000. BIRinging chromosomes through cell division-and survivin' the experience. Cell. 102:545-548.
5. Li, F., G. Ambrosini, E.Y. Chu, J. Plescia, S. Tognin, P.C. Marchisio, and D.C. Altieri. 1998. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature. 396:580-583.
6. Rodriguez, J.A., S.W. Span, C.G. Ferreira, F.A. Kruyt, and G. Giaccone. 2002. CRM1-mediated nuclear export determines the cytoplasmic localization of the antiapoptotic protein survivin. Exp. Cell Res. 275:44-53.
7. Song, Z., X. Yao, and M. Wu. 2003. Direct interaction between survivin and Smac is essential for the anti-apoptotic activity of survivin during taxol-induced apoptosis. J. Biol. Chem. 278:23130-23140.
8. Banks, D.P., J. Plescia, D.C. Altieri, J. Chen, S.H. Rosenberg, H. Zhang, and S.C. Ng. 2000. Survivin does not inhibit caspase-3 activity. Blood. 96:4002-4003.
9. Verdecia, M.A., H. Huang, E. Dutil, A. Kaiser, T. Hunter, and J.P. Noel. 2000. Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement. Nat. Struct. Biol. 7:620-623.
10. Ambrosini, G., C. Adida, and D.C. Altieri. 1997. A novel anti-apoptotic gene, survivin, expressed in cancer and lymphoma. Nat. Med. 3:917-921.
11. Monzo, M., R. Rosell, E. Felip, J. Astudillo, J.J. Sanchez, J. Maestre, C. Martin, A. Font, A. Bamadas, and A. Abad. 1999. A novel anti-apoptosis gene: re-expression of survivin messenger RNA as a prognostic marker in non-small cell lung cancers. J. Clin. Oncol. 17:2100-2104.
12. Altieri, D.C. 2003. Validating survivin as a cancer therapeutic target. Nat. Rev. 4:46-54.
13. Olie, R.A., A.P. Simoes-Wust, B. Baumann, S.H. Leech, D. Fabbro, R.A. Stahel, and U. Zangemeister-Wittke. 2000. A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy. Cancer Res. 60:2805-2809.
14. De Mesaeker, A., R. Häner, P. Martin, and H.E. Moser. 1995. Antisense oligonucleotides. Acc. Chem. Res. 28:366-374.
15. Cowland, J.B., and N. Borregaard. 1999. Isolation of neutrophil precursors from bone marrow for biochemical and transcriptional analysis. J. Immunol. Methods. 232:191-200.
16. Borregaard, N., M. Sehested, B.S. Nielsen, H. Sengelov, and L. Kjeldsen. 1995. Biosynthesis of granule proteins in normal human bone marrow cells. Gelatinase is a marker of terminal neutrophil differentiation. Blood. 85:812-817.
17. Terstappen, L.W.M.M., M. Safford, and M.R. Loken. 1990. Flow cytometric analysis of human bone marrow. III. Neutrophil maturation. Leukemia. 4:657-663.
18. Yousefi, S., D.R. Green, K. Blaser, and H.-U. Simon. 1994. Protein tyrosine phosphorylation regulates apoptosis in human eosinophils and neutrophils. Proc. Natl. Acad. Sci. USA. 91:10868-10872.
19. Dibbert, B., M. Weber, W.H. Nikolaizik, P. Vogt, M.H. Schöni, K. Blaser, and H.-U. Simon. 1999. Cytokine-mediated Bax deficiency and consequent delayed neutrophil apoptosis: a general mechanism to accumulate effector cells in inflammation. Proc. Natl. Acad. Sci. USA. 96:13330-13335.
20. Conway, E.M., S. Pollefeyt, M. Steiner-Mosonyi, W. Luo, A. Devriese, F. Lupu, F. Bono, N. Leducq, F. Dol, P. Schaeffer, et al. 2002. Deficiency of survivin in transgenic mice exacerbates Fas-induced apoptosis via mitochondrial pathways. Gastroenterology. 123:619-631.
21. Daigle, I., S. Yousefi, M. Colonna, D.R. Green, and H.-U. Simon. 2002. Death receptors bind SHP-1 and block cytokine-induced anti-apoptotic signaling in neutrophils. Nat. Med. 8:61-67.
22. Heinisch, I.V., I. Daigle, B. Knöpfli, and H.U. Simon. 2000. CD137 activation abrogates granulocyte-macrophage colony-stimulating factor-mediated anti-apoptosis in neutrophils. Eur. J. Immunol. 30:3441-3446.
23. Hebestreit, H., B. Dibbert, I. Balatti, D. Braun, A. Schapowal, K. Blaser, and H.-U. Simon. 1998. Disruption of Fas receptor signaling by nitric oxide in eosinophils. J. Exp. Med. 187:415-425.
24. Altznauer, F., S. Conus, A. Cavalli, G. Folkers, and H.-U. Simon. 2004. Calpain-1 regulates Bax and subsequent Smac-dependent caspase-3 activation in neutrophil apoptosis. J. Biol. Chem. 279:5947-5957.
25. Simon, H.-U., S. Yousefi, C. Schranz, A. Schapowal, C. Bachert, and K. Blaser. 1997. Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. J. Immunol. 158:3902-3908.
26. Simon, H.-U., M. Weber, E. Becker, Y. Zilberman, K. Blaser, and F. Levi-Schaffer. 2000. Eosinophils maintain their capacity to signal and release eosinophil cationic protein upon repetitive stimulation with the same agonist. J. Immunol. 165:4069-4075.
27. L and Bax-α-mediated regulation of apoptosis of human neutrophils via caspase-3. Blood. 93:3106-3115.
28. Daigle, I., and H.-U. Simon. 2001. Critical role for caspase-3 in neutrophil but not eosinophil apoptosis. Int. Arch. Allergy Immunol. 126:147-156.
29. Maianski, N.A., F.P.J. Mul, J.D. van Buul, and T.W. Kuijpers. 2002. Granulocyte colony-stimulating factor inhibits the mitochondria-dependent activation of caspase-3 in neutrophils. Blood. 99:672-679.
30. Kallio, M.J., M. Nieminen, and J.E. Eriksson. 2001. Human inhibitor of apoptosis protein (IAP) survivin participates in regulation of chromosome segregation, and mitotic exit. FASEB J. 15:2721-2723.
31. Kobayashi, S., K. Yamashita, T. Takeoka, T. Ohtsuki, Y. Suzuki, R. Takahashi, K. Yamamoto, S.H. Kaufmann, T. Uchiyama, M. Sasada, and A. Takahashi. 2002. Calpain-mediated X-linked inhibitor of apoptosis degradation in neutrophil apoptosis and its impairment in chronic neutrophilic leukemia. J. Biol. Chem. 277:33968-33977.
32. Moulding, D.A., C. Akgul, M. Derouet, M.R.H. White, and S.W. Edwards. 2001. Bcl-2 family expression in human neutrophils during delayed and accelerated apoptosis. J. Leukoc. Biol. 70:783-792.
33. Baumann, R., C. Casaulta, D. Simon, S. Conus, S. Yousefi, and H.-U. Simon. 2003. Macrophage migration inhibitory factor delays apoptosis in neutrophils by inhibiting the mitochondria-dependent death pathway. FASEB J. 17:2221-2230.
34. + cells by hematopoietic growth factors: implication of survivin expression in normal hematopoiesis. Blood. 98:2091-2100.
35. Devereaux, Q.L., R. Takahashi, G.S. Salvesen, and J.C. Reed. 1997. X-linked IAP is a direct inhibitor of cell-death proteases. Nature. 388:300-304.
36. Bratton, S.B., and G.M. Cohen. 2003. Death receptors leave a caspase footprint that Smacs of XIAP. Cell Death Differ. 10:4-6.
37. Martinou, I., S. Desagher, R. Eskes, B. Antosson, E. Andre, S. Fakan, and J.C. Martinou. 1999. The release of cytochrome c from mitochondria during apoptosis of NGF-deprived sympathetic neurons is a reversible event. J. Cell Biol. 144:883-889.
38. Holcik, M., H. Gibson, and R.G. Komeluk. 2001. XIAP: apoptotic break and promising therapeutic target. Apoptosis. 6:253-261.
39. Hasegawa, T., K. Suzuki, C. Sakamoto, K. Ohta, S. Nishiki, M. Hino, N. Tatsumi, and S. Kitagawa. 2003. Expression of the inhibitor of apoptosis (IAP) family members in human neutrophils: up-regulation of cIAP2 by granulocyte colony-stimulating factor and overexpression of cIAP2 in chronic neutrophilic leukemia. Blood. 101:1164-1171.
40. Simon, H.-U. 2003. Neutrophil apoptosis pathways and their modifications in inflammation. Immunol. Rev. 193:101-110.
41. Uren, A.G., L. Wong, M. Pakusch, K.J. Fowler, F.J. Burrows, D.L. Vaux, and K.H. Choo. 2000. Survivin, and the inner centromere protein INCENP show similar cell-cycle localization, and gene knockout phenotype. Curr. Biol. 10:1319-1328.
42. Skoufias, D.A., C. Mollinari, F.B. Lacroix, and R.L. Margolis. 2000. Human survivin is a kinetochore-associated passenger protein. J. Cell Biol. 25:1575-1582.
43. Wheatley, S.P., A. Carvalho, P. Vagnarelli, and W.C. Earnshaw. 2001. INCENP is required for proper targeting of survivin to the centromeres, and the anaphase spindle during mitosis. Curr. Biol. 11:886-890.
44. + cells and modulates cell cycle and proliferation of mouse hematopoietic progenitor cells. Blood. 100:2463-2471.
45. WAF1/Cip1 dependent and independent pathways. Blood. 103:120-127.
46. Xing, X., E.M. Conway, C. Kang, and A. Winoto. 2004. Essential role of survivin, an inhibitor of apoptosis protein, in T cell development, maturation, and homeostasis. J. Exp. Med. 199:69-80.